Sports Medicine – Current and Future Players, New Report Launched

This report focuses on the sports medicine market, which includes implants and arthroscopic capital equipment. The orthopedic sports medicine market has been estimated in this report and covers the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India. The report provides unmet needs, future adoption and compound annual growth rates (CAGR). Publisher’s analysis shows that while the orthopedics implant market is mature, sports medicine is an area with the potential for significant international growth. With the market, the US remains to be the largest market with the EU to follow and growing. The APAC region while markedly smaller has a large potential patient population.The top six to seven market leaders continue to dominate the market through technological innovation and investment in establishing strong distribution networks. The major opportunity lies within technological advancement and the clinical trials to prove effectiveness of new techniques.

The report identifies and analyzes the key companies shaping and driving the Sports Medicine market. The report provides insight into the competitive Sports Medicine landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading doctors, with in-house analysis conducted by Publisher’s team of industry experts.

Scope

  • Investigation of current and future market competition for Sports Medicine
  • Competitor assessment including device approval analysis.
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Sports Medicine in clinical practice.

Reasons to buy

  • Gain a high level view of the trends shaping and driving the Sports Medicine market.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
  • Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Spanning Over 100 pages, 64 tables, “MediPoint – Sports Medicine – Current and Future Players” report covering the Competitive Assessment, Pipeline Assessment, Current and Future Players, Appendix. The report covered 9 companies – Arthrex, ArthroCare Corporation, Biomet, ConMed Corporation, DePuy Companies, Smith & Nephew, Stryker, Tornier, Wright Medical Group.

Know more about this report at: http://mrr.cm/ZTT

Related Report;

1st – MediPoint: Sports Medicine – EU Analysis and Market Forecasts – See more at: http://mrr.cm/ZTq

2nd – MediPoint: Sports Medicine – South America Analysis and Market Forecasts – See more at: http://mrr.cm/ZTc

About Market Research Reports, Inc.

Market Research Reports, Inc. is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketReserachReports.com: The Global Ostomy Drainage Bags Market to Reach $3.1 billion by 2019, Reveals New Report

The global ostomy drainage bags market is forecast to increase from $2.2 billion in 2012 to $3.1 billion by 2019, at a Compound Annual Growth Rate (CAGR) of 5%, finds new report.

According to the company’s latest ” Ostomy Drainage Bags Market to 2019 – Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential” report, the increasing prevalence of conditions such as colorectal cancer, inflammatory bowel disease and prostate cancer, which require surgery and the creation of a fecal or urinary stoma, is the major driver for the forecast growth.

In 2012, three top companies accounted for more than 80% of the global market, with Coloplast, Convatec and Hollister having shares of 37%, 28% and 17%, respectively.

Technical advances in ostomy bags will also be a major driver for growth during the forecast period.

Report’s lead Analyst covering Medical Devices, says: “In addition to progress in urinary and fecal diversions, complications such as morbidity associated with radical pelvic surgery and major surgical procedures have massively reduced. Other significant advances include the improved ability to identify autonomic nerves, while increased use of laparoscopy reduces the risk of post-operative morbidity and recovery time.”

However, the unfavorable reimbursement scenario for ostomy drainage bags in developed countries is expected to limit future growth. In the US, inadequate reimbursement encourages ostomates to prolong the usage of ostomy drainage bags beyond their average lifetime, which limits demand for new ones. In Europe, many countries, with the exception of Germany and France, do not have fixed reimbursement fees for the procedure.

“In 2012, Eucomed, an association of various stakeholders in the medical device industry, announced proposals to address the challenges in the reimbursement provided for ostomy. These non-profit associations, combined with companies pushing for better reimbursement scenarios, are vital for the future growth of the ostomy drainage bags market,” says analyst.

In countries such as India and China, there is currently no reimbursement for ostomy surgeries, and a lack of awareness of this issue could be a major restraint to companies expanding into these under-penetrated markets.

This report looks at the market, key market players, and market dynamics for the global ostomy drainage bags market. It provides a synopsis of the various factors influencing this market. This report also gives company descriptions and lists the key marketed products for major market players.

Spanning over 48 pages, 33 tables and 30 figures, “Ostomy Drainage Bags Market to 2019 – Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential” report provides information on market overview, drivers and challenge, competition and key trends.

In addition to covering the Global Ostomy Drainage Bags Market: Device Overview, Global Ostomy Drainage Bags Market: Market Characterization, Global Ostomy Drainage Bags Market: Country-Wise Revenue (2005–2019), Global Ostomy Drainage Bags Market: Company Profiles. The report covers 5 companies – Coloplast A/S, ConvaTec Inc., Hollister Incorporated, Dansac A/S, B. Braun Melsungen AG.

Find all Medical Devices market research reports under a single page.

Find all Pharma and Healthcare market research reports under a single page.

About Market Research Reports, Inc.

Market Research Reports, Inc. (MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketReserachReports.com: Asia Pacific Solid Tumors Market to Reach $2.3 Billion by 2019, Reveals New Report

The Asia-Pacific solid tumors treatment markets – bladder, ovarian, pancreatic and prostate cancers – is expected to grow from $1 billion in 2012 to $2.3 billion in 2019, at a Compound Annual Growth Rate (CAGR) of 12.3%, forecasts new business report.

According to the company’s latest “ Solid Tumors Market in Asia Pacific to 2019 – New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies ” report, the fastest growing market for solid tumors in the Asia-Pacific region is Australia, achieving an expected CAGR of 13.9% by the end of the forecast period. A slower growth rate is expected in India (9.7%) and China (5.5%), due primarily to stricter pricing regulations and recent price cuts.

The average cost of treatment for the four cancer types mentioned previously is also estimated to grow from $4,001 in 2012 to $6212.5 by 2019, at a CAGR of 6.5%. The cost of treatment in Australia will be even higher, increasing from $3,703 in 2012 to $7,576 by 2019, at a CAGR of 10.8, driven mainly by better access and speedier launches of new drugs in the country.

According to lead analyst of this report; “The solid tumors treatment market is expected to show modest growth over the forecast period due to recent drug approvals and expected product launches for ovarian, pancreatic and prostate cancers. These new approvals, which have occurred in the last two years, have the potential to influence disease treatment patterns and may therefore have an effect on market size.”

With the Chinese government’s ambitious plans for healthcare reforms, access to healthcare facilities and drugs is expected to increase in the coming decade, which could be a major driver for the solid tumors market, although pricing regulation in China and India could restrict potential growth.

“In recent years, several attempts were made by the pricing and regulatory bodies in both India and China to improve access and affordability of innovative drugs. In late 2012, Indian government approved regulations to cap prices of 348 drugs on the Essential Drugs List (EDL). Additionally, manufacturers are required to price their drugs below the ceiling price, which is fixed by taking an average cost of all drugs that have more than 1% market share,” says Vulapalli.

However, a number of recent drugs have been approved in Australia and Japan, including Afinitor, Avastin, Jevtana, Sutent and Zytiga, which could trigger a shift in the treatment paradigm in the foreseen future.

This report analyzes treatment usage patterns, market characterization, pipeline analysis and key licensing and co-development deals in the bladder cancer, ovarian cancer, pancreatic cancer and prostate cancer in the four APAC markets of Australia, China, India and Japan.

Spanning over 111 pages, 27 tables and 37 figures, “Solid Tumors Market in Asia Pacific to 2019 – New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies” report provides information on market overview, drivers and challenge, competition and key trends.

In addition to covering the Solid Tumors Market in Asia Pacific to 2019 – Introduction, Therapeutic Landscape, Marketed Products, Pipeline Analysis,  Market Forecast, Deals and Strategic Consolidations.

Find all Pharma and Healthcare market research reports under a single page.

Find all Medical Diseases market research reports under a single page.

About Market Research Reports, Inc.

Market Research Reports, Inc. (MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: Japanese Market for Wound and Tissue Management, New Report Launched

The wound and tissue management market includes wound closure devices, moist dressings, antimicrobial dressings, interactive dressings, traditional dressings, hemostats, tissue sealants, anti-adhesion products and negative pressure wound therapy. Products can be divided into external, internal and combined wound management. This market is expected to be driven by the increasing aging population, rising rates of obesity and diabetes, as well as the increased device efficiency. This report details the expected growth rates, average selling prices (ASP) and market values of the interlinked segments mentioned above.

Summary of the following:

Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for Japan.

Report Contents: Competitor Analysis Identified Strategic Opportunities Market Overview by Segment Trend Analysis by Segment Market Drivers & Limiters Mergers & Acquisitions Customer Feedback and Market Monitoring Main Segments Included: Wound Closure Market Advanced Dressings Market Tissue Sealant Market Hemostats Market Anti-Adhesion Market Negative Pressure Wound Therapy Market Traditional Dressings Market.

Spanning over 164 pages, figures and charts, “Japanese Market for Wound and Tissue Management” report provides information on market overview, drivers and challenge, competition and key trends.

In addition to covering the Executive summary, Research methodology, Japanese wound and tissue management market overview, Wound closure market, Advanced dressings market overview, Moist dressings market, Antimicrobial dressings market, Interactive dressings market, Tissue sealant market, Anti-adhesion market, Negative pressure wound therapy market, Appendix 1: Traditional dressings market, Appendix 2: Hemostats market, Abbreviations.

For more information visit: Japanese Market for Wound and Tissue Management

Find all Pharma and Healthcare market research reports under a single page.

Find all Treatments market research reports under a single page.

About Market Research Reports, Inc.

Market Research Reports, Inc. (MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: European Video, High-Tech and Integrated OT Equipment , New Report Launched

In 2012, the integrated operating theatre market increased significantly, which was partly due to the emergence of new companies who introduced an array of products. This has resulted in the market for integrated OTs being segmented into the digitized integration component market and the full integration component market. Digitalization and routing of endoscopic equipment in the OT is currently driving the market along because of the desire and the need to record images and video for teaching and legal purposes.

The European markets for video, high-tech and integrated operating theatre equipment were valued at over €1 billion in 2012 and the fastest growing segment was the integrated operating theatre market.

As technology improves, minimally invasive techniques are expected to be applied to more procedures, resulting in an increased need for integration. The trend over the forecast period will be towards fully integrated OTs. As countries begin to recover from the economic recession, full integration component systems will comprise even more of the market by 2019.

This report pertains to a forecast period of 10 years (2009 – 2019) for:

Germany, France, U.K, Italy, Spain, Benelux, Scandinavia, Portugal, Austria, Switzerland, Japan, South Korea and Australia.

Report Contents:

  • Competitor Analysis
  • Identified Strategic Opportunities
  • Market Overview by Segment & Country
  • Trend Analysis by Segment & Country
  • Market Drivers & Limiters
  • Mergers & Acquisitions
  • Customer Feedback and Market Monitoring

Main Segments Included:

  • Integrated Operating Room (OR) Market
  • Surgical Camera System Market
  • Image Capture and Recording Device Market
  • Surgical Display and PACs Monitor Market
  • Medical Printer Market
  • Surgical Light Source Market
  • Surgical Headlight Market
  • Surgical Lighting Market
  • Surgical Boom Market
  • Surgical Table Market
  • Insufflation Device Market
  • Surgical Microscope Market

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.  For more information visit: European Video, High-Tech and Integrated OT Equipment (15 Countries)

Summary of the following markets:

  • Integrated Operating Room (OR) Market
  • Surgical Camera System Market
  • Image Capture and Recording Device Market
  • Surgical Display and PACs Monitor Market
  • Medical Printer Market
  • Surgical Light Source Market
  • Surgical Headlight Market
  • Surgical Lighting Market
  • Surgical Boom Market
  • Surgical Table Market
  • Insufflation Device Market
  • Surgical Microscope Market

Spanning over 436 pages, figures and charts, “European Video, High-Tech and Integrated OT Equipment (15 Countries)” report provides information on market overview, drivers and challenge, competition and key trends.

In addition to covering the Executive summary, European markets for video – high-tech and integrated operating theatre equipment, Research methodology, European video – high-tech and operating theatre equipment market, Country profiles, Integrated operating theatre market, Surgical camera system market, Image capture and recording device market, Surgical display market, Surgical light source market, Theatre lighting market, Market analysis and forecast, Surgical boom market, Surgical table market, Surgical microscope market, Surgical headlight market, Abbreviations.

Find all Pharma and Healthcare market research reports under a single page.

Find all Medical Devices market research reports under a single page.

About Market Research Reports, Inc.

Market Research Reports, Inc. (MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: Brazilian Market for Orthopedic Soft Tissue Repair & Sports Medicine, New Report Launched

All segments of the Brazilian orthopaedic soft tissue repair market are being fueled by medical industry growth in Brazil. Every year more hospitals are being built in Brazil, and thus demand increases for soft tissue repair products. Additionally, with the growing economy, more money is being spent on improving the health care system, leading to an increase in the number of people able to afford private insurance. The prices of products sold in the private health care system are 3 to 5 times higher than prices of products sold to public hospitals, which will further fuel market growth over the forecast period.Brazilian orthopedic soft tissue repair market reached $394.5 million in 2012.

Report Contents:

  • Competitor Analysis
  • Identified Strategic Opportunities
  • Market Overview by Segment & Country
  • Trend Analysis by Segment & Country
  • Market Drivers & Limiters
  • Mergers & Acquisitions
  • Customer Feedback and Market Monitoring

Main Markets Included:

  • ACL/PCL Fixation Devices
  • Meniscal Repair
  • Rotator Cuff Repair
  • Shoulder Labrum Repair
  • Hip Arthroscopy
  • Biceps Tenodesis

Spanning over 154 pages, figures and charts, “Brazilian Market for Orthopedic Soft Tissue Repair & Sports Medicine” report provides information on market overview, drivers and challenge, competition and key trends.

In addition to covering the Brazilian market for orthopedic soft tissue repair, Research scope, Brazilian market for orthopedic soft tissue repair, ACL/PCL fixation device market, Meniscal repair market, Rotator cuff repair market, Shoulder labrum repair market, Hip arthroscopy market, Biceps Tenodesis repair market.

Find all Pharma and Healthcare market research reports under a single page.

Find all Treatments market research reports under a single page.

About Market Research Reports, Inc.

Market Research Reports, Inc. (MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: PharmaSphere: Asia Pacific Deal Trends, 2004-2013, New Report Launched

PharmaSphere: Asia Pacific Deal Trends, 2004-2013 report offers an in-depth understanding of the key deals that took place in the region during the last decade. The type of deals covered in the report include Mergers & Acquisitions (M&A), Licensing and Collaboration & Partnerships. The report also provides understanding on the regional differences in the deal making activity to that of the global trends and key trends are outlined with insight on drivers such as regulatory policy, macro-economic and industry factors as well as market access challenges. Case studies including the top deals in value among Mergers & Acquisition, Licensing and Collaboration & Partnerships are strategically analyzed to provide comprehensive understanding on areas such as structure and status of the deal vis a vis the overall corporate strategy.

The report is an essential source of information and analysis on strategic deals in the Asia Pacific region. It includes top players in the global and regional pharmaceuticals and healthcare market. Using detailed company data and financial analysis, publisher has highlighted certain deals in the pharmaceutical market, forming a basis for in-depth analysis of the factors driving deal-making in the industry, currently and into the future. The report discusses the key factors shaping and driving the pharmaceutical industry in the Asia Pacific region, and provides insight on the competitive landscape and emerging strategies that are expected to significantly alter the market position of industry leaders.

Key Questions Answered-

  • How are the main deal categories faring among top countries in the Asia Pacific region over the past decade?
  • What are the primary reasons for increased activity in strategic deals by leading pharmaceutical companies in APAC region?
  • What are the key trends, and strategies involved in M&As, licensing deals, and collaboration agreements entered into by leading pharmaceutical and healthcare companies in the Asia Pacific region?
  • What strategies are the most successful companies pursuing to gain and maintain their market leading position?

Scope-

  • In-depth understanding of the key pharmaceutical and healthcare deals that took place in the APAC region during the last decade. Furthermore, key deals are discussed from a domestic and global point of view
  • Current regulatory framework in various markets in APAC including recent and/or ongoing developments that are expected to impact or influencing the industry are discussed
  • Dealmaking strategies: insightful analysis on the terms, strategic implications and synergies of recent -deals activity in the APAC pharmaceutical industry
  • Collaboration and acquisition strategies: exhaustive discussion on the strategic implications and synergies of recent M&A and partnering activities
  • Expert insights on the corporate strategies of various drug companies seeking a competitive advantage in the pharmaceutical market place
  • Case studies on top deal making activities shedding light on rationale and strategy.

Reasons to buy-

  • Understand the primary drivers behind major deal initiatives in the APAC region.
  • Analyze the structures of the deal and gain insight on the various factors considered when structuring deal terms in strategic acquisitions, mergers, collaborations, and licensing.
  • Identify rationale behind potential takeover targets and partners, thereby maximizing your opportunities for consolidation, investment, and strategic partnerships in the Asia Pacific region.
  • Use this information as an independent source for your due diligence and transaction strategy.

Spanning over 71 pages, 22 tables and 7 figures, “PharmaSphere: Asia Pacific Deal Trends, 2004–2013” report provides information on market overview, drivers and challenge, competition and key trends.

In addition to covering the Historical Dealmaking Trends, Mergers and Acquisitions, Licensing Arrangements, Collaborations and Partnerships, Future Outlook, Case Studies.

Find all Pharma and Healthcare market research reports under a single page.

Find all Medical Diseases market research reports under a single page.

About Market Research Reports, Inc.

Market Research Reports, Inc. (MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: Prostate Cancer – Pipeline Review, H2 2013, New Report Launched

Prostate Cancer – Pipeline Review, H2 2013 report provides an overview of the indication’s therapeutic pipeline. This report also reviews key players involved in the therapeutic development for Prostate Cancer. Prostate Cancer – Pipeline Review, Half Year is built using data and information sourced from publisher proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by publisher team.

Scope

  • A snapshot of the global therapeutic scenario for Prostate Cancer.
  • A review of the Prostate Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Prostate Cancer pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Identify and understand important and diverse types of therapeutics under development for Prostate Cancer.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Prostate Cancer pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Spanning over 413 pages, 271 tables and 14 figures, “Prostate Cancer – Pipeline Review, H2 2013” report provides information on the therapeutic development for Prostate Cancer, complete with latest updates, and special features on late-stage and discontinued projects.

In addition to covering the Prostate Cancer Overview, Late Stage Products, Mid Clinical Stage Products, Early Clinical Stage Products, Discovery and Pre-Clinical Stage Products, Companies Involved in Prostate Cancer Therapeutics Development, Prostate Cancer Therapeutics – Drug Profile Updates, Prostate Cancer Therapeutics – Discontinued Products, Prostate Cancer Therapeutics – Dormant Products, Prostate Cancer – Product Development Milestones.  The report covers 185 companies; few are Bio-Path Holdings, Inc., ZIOPHARM Oncology, Inc., Millennium Pharmaceuticals, Inc., Novartis AG, Aphios Corporation, Astellas Pharma Inc., BioMarin Pharmaceutical Inc., GTx, Inc., Nippon Shinyaku Co., Ltd., Orion Corporation, Pfizer Inc., SuperGen, Inc., Anavex Life Sciences Corp., ValiRx Plc, Active Biotech AB, AEterna Zentaris Inc.

Find all Pharma & Healthcare Industry Reports under a single page at: Pharma and Healthcare Market Research Reports

About Market Research Reports, Inc.

Market Research Reports, Inc. (www.MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: Non-Small Cell Lung Cancer – Pipeline Review, H2 2013, New Report Launched

Non-Small Cell Lung Cancer – Pipeline Review, H2 2013 report provides an overview of the indication’s therapeutic pipeline. This report also reviews key players involved in the therapeutic development for Non-Small Cell Lung Cancer. Non-Small Cell Lung Cancer – Pipeline Review, Half Year is built using data and information sourced from publisher  proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by publisher team. For more information visit: Non-Small Cell Lung Cancer – Pipeline Review, H2 2013

Scope

  • A snapshot of the global therapeutic scenario for Non-Small Cell Lung Cancer.
  • A review of the Non-Small Cell Lung Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Non-Small Cell Lung Cancer pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Identify and understand important and diverse types of therapeutics under development for Non-Small Cell Lung Cancer.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Non-Small Cell Lung Cancer pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Spanning over 447 pages, 234 tables and 14 figures, “Non-Small Cell Lung Cancer – Pipeline Review, H2 2013”  report provides information on the therapeutic development for Non-Small Cell Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects.

In addition to covering the Non-Small Cell Lung Cancer Overview, Non-Small Cell Lung Cancer Therapeutics under Development by Companies, Non-Small Cell Lung Cancer Therapeutics under Investigation by Universities/Institutes, Late Stage Products, Mid Clinical Stage Products, Early Clinical Stage Products, Discovery and Pre-Clinical Stage Products, Companies Involved in Non-Small Cell Lung Cancer Therapeutics Development, Non-Small Cell Lung Cancer Therapeutics – Drug Profile Updates, Non-Small Cell Lung Cancer Therapeutics – Discontinued Products, Non-Small Cell Lung Cancer Therapeutics – Dormant Products, Non-Small Cell Lung Cancer – Product Development Milestones.  The report covers 138 companies; few are Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Biogen Idec Inc., Shionogi & Co., Ltd., Amgen Inc., Sanofi-Aventis, AstraZeneca PLC, Eli Lilly and Company, GlaxoSmithKline plc, Genentech, Inc., Nektar Therapeutics, Inovio Biomedical Corporation, MedImmune LLC.

Find all: Pharma and Healthcare Market Research Reports

About Market Research Reports, Inc.

Market Research Reports, Inc. (www.MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: Alzheimer’s Disease – Pipeline Review, H2 2013, New Report Launched

Alzheimer’s Disease – Pipeline Review, H2 2013 report provides an overview of the indication’s therapeutic pipeline. This report also reviews key players involved in the therapeutic development for Alzheimer’s Disease. Alzheimer’s Disease – Pipeline Review, Half Year is built using data and information sourced from publisher proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by publisher team.

Scope

  • A snapshot of the global therapeutic scenario for Alzheimer’s Disease.
  • A review of the Alzheimer’s Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Alzheimer’s Disease pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Identify and understand important and diverse types of therapeutics under development for Alzheimer’s Disease.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Alzheimer’s Disease pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Spanning over 297 pages, 260 tables and 10 figures, “ Alzheimer’s Disease – Pipeline Review, H2 2013 ” report provides information on the therapeutic development for Alzheimer’s Disease, complete with latest updates, and special features on late-stage and discontinued projects.

In addition to covering the Alzheimer’s Disease Overview, Late Stage Products, Mid Clinical Stage Products, Early Clinical Stage Products, Discovery and Pre-Clinical Stage Products, Companies Involved in Alzheimer’s Disease Therapeutics Development, Alzheimer’s Disease Therapeutics – Drug Profile Updates, Alzheimer’s Disease Therapeutics – Discontinued Products, Alzheimer’s Disease Therapeutics – Dormant Products. The report covers 170 companies; few are Bristol-Myers Squibb Company, Johnson & Johnson, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Biogen Idec Inc., OXIS International, Inc., Shionogi & Co., Ltd., NsGene A/S, Amgen Inc., Sanofi-Aventis, AstraZeneca PLC, Eli Lilly and Company. Find all: Pharma and Healthcare Market Research Reports

About Market Research Reports, Inc.

Market Research Reports, Inc. (www.MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.